T - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87278810
Serial Number
87278810
Registration Number
5857855
Word Mark
T
Status
700 - Registered
Status Date
2019-09-10
Filing Date
2016-12-22
Registration Number
5857855
Registration Date
2019-09-10
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260102, 260121, 260508, 260521, 270301 - Plain single line circles. Circles that are totally or partially shaded. Letters, numerals or punctuation forming the perimeter of a triangle, bordering the perimeter of a triangle or forming a triangle. Triangles that are completely or partially shaded. Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2017-05-30
Attorney Name
Jennifer Lee Taylor
Law Office Assigned Location Code
L20
Employee Name
FERRAIUOLO, DOMINIC J
Statements
Indication of Colors claimed
The color(s) red and white is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a stylized letter "T" with the top left half in the color red, forming the left edge of a triangle that is red with a dot in the middle in the color white and that includes within it the top right and bottom of the letter "T" in white.
Goods and Services
Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-01-06
Primary Code
005
First Use Anywhere Date
2019-02-26
First Use In Commerce Date
2019-02-26
Current Trademark Owners
Party Name
Titan Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Titan Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Titan Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Titan Pharmaceuticals, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JENNIFER LEE TAYLOR
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0067843
Original Filing Date USPTO
2017-06-16
International Registration Number
1370158
International Registration Date
2017-06-16
International Status Code
480
International Renewal Date
2027-06-16
Madrid History Events
DateCodeDescription
2019-12-10CBPCPPARTIAL CEASING OF EFFECT TO BE PROCESSED
2017-08-05IRREGIRREGULARITY NOTICE RECEIVED FROM IB
2017-08-15IRRCVIRREGULARITY RESPONSE RECEIVED FROM APPLICANT
2020-01-10CBNARCEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE
2017-10-19CREATAPPLICATION FOR IR REGISTERED BY IB
2017-06-16ACERTAUTOMATICALLY CERTIFIED
2017-06-16NEWAPNEW APPLICATION FOR IR RECEIVED
2017-06-16APPSTIR CERTIFIED AND SENT TO IB
2017-08-16IRRACRESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED
2017-08-16IRSNTIRREGULARITY RESPONSE SENT TO IB
Trademark Events
Event DateEvent Description
2016-12-27NEW APPLICATION ENTERED IN TRAM
2017-01-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-01-07NOTICE OF DESIGN SEARCH CODE E-MAILED
2017-03-22ASSIGNED TO EXAMINER
2017-03-28EXAMINERS AMENDMENT -WRITTEN
2017-03-28EXAMINERS AMENDMENT E-MAILED
2017-03-28NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-03-28EXAMINER'S AMENDMENT ENTERED
2017-03-28APPROVED FOR PUB - PRINCIPAL REGISTER
2017-05-10NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-05-30PUBLISHED FOR OPPOSITION
2017-05-30OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-07-25NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-01-18TEAS EXTENSION RECEIVED
2018-01-18EXTENSION 1 FILED
2018-01-18EXTENSION 1 GRANTED
2018-01-20NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-03-28ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2018-06-27TEAS EXTENSION RECEIVED
2018-06-27EXTENSION 2 FILED
2018-06-27EXTENSION 2 GRANTED
2018-06-29NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-01-16TEAS EXTENSION RECEIVED
2019-01-16EXTENSION 3 FILED
2019-01-16EXTENSION 3 GRANTED
2019-01-18NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-07-09TEAS STATEMENT OF USE RECEIVED
2019-07-29CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-07-09USE AMENDMENT FILED
2019-07-30STATEMENT OF USE PROCESSING COMPLETE
2019-08-02ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2019-08-03NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2019-09-10REGISTERED-PRINCIPAL REGISTER